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Abstract.  Interleukin-I (IL-1) is synthesized by and 
released from macrophages in response to a variety of 
stimuli and appears to play an essential role in virtu- 
ally all inflammatory conditions. In tissues of mesen- 
chymal origin (e.g., cartilage,  muscle, bone, and soft 
connective tissue) ILl  induces changes characteristic 
of both destructive as well as reparative phenomena. 
Previous studies with natural IL-1 of varying degrees 
of purity have suggested that it is capable of modulat- 
ing a number of biological activities of fibroblasts. We 
have compared the effects of purified human recom- 
binant (hr) IL-la and !~ on several fibroblast functions. 
The parameters studied include cell proliferation, 
chemotaxis, and production of collagen, collagenase, 
tissue inhibitor of metalloproteinase (TIMP),  and pros- 
taglandin (PG) E2. We observed that hrlL-ls stimulate 
the synthesis and accumulation of type I procollagen 
chains. Intracellular degradation of collagen is not al- 
tered by the hrlL-ls. Both IL-ls were observed to in- 
crease the steady-state levels of pro al(I) and pro a2(I) 
mRNAs, indicating that they exert control of type I 
procollagen gene expression at the pretranslational 
level. We found that both hrlL-la and 13 stimulate syn- 
thesis of TIMP, collagenase, PGE2, and growth of 
fibroblasts in vitro but are not chemotactic for fibro- 
blasts. Although hrlL-la and 13 both are able to stimu- 
late production of PGE2 by fibroblasts, inhibition of 
prostaglandin synthesis by indomethacin has no mea- 
surable effect on the ability of the IL-ls to stimulate 
cell growth or production of collagen and collagenase. 
Each of the IL-ls stimulated proliferation and collagen 
production by fibroblasts to a  similar degree, however 
hrlL-113 was found to be less potent than hrlL-1 a  in 
stimulating PGE2 production. These observations sup- 
port the notion that IL-l~t and 13 may both modulate 
the degradation of collagen at sites of tissue injury by 
virtue of their ability to stimulate collagenase and 
PGE2 production by fibroblasts.  Furthermore, IL-la 
and 13 might also direct reparative functions of fibro- 
blasts by stimulating their proliferation and synthesis 
of collagen and TIMP. 
S 
TUDIES with natural interleukin-1  (IL-t) ~  of varying de- 
grees of purity have suggested that this monokine may 
play a pivotal role in modulating the biological activi- 
ties of a variety of target cells.  Effects attributed to IL-1 on 
immune and inflammatory cells have been previously re- 
viewed (26). Several other factors named for a specific bio- 
logical activity now appear to be identical or related to IL-1; 
these include endogenous pyrogen, leukocyte endogenous 
1. Abbreviations used in this paper: hrlL-la and I$, human recombinant a 
and 13; IL-1, interleukin 1; PGE2, prostaglandin E2; TIMP, tissue inhibitor 
of metalloproteinase. 
mediators, catabolin, mononuclear cell factor, and proteoly- 
sis inducing factor (26). 
The biological activities of mesenchymal cells involved in 
the synthesis and maintenance of the extracellular matrix are 
affected by IL-1. IL-1 promotes growth of fibroblasts and os- 
teoblasts and increases alkaline phosphatase production by 
the  latter  (15, 27).  Dermal  fibroblasts,  adherent synovial 
cells, and chondrocytes produce increased quantities of col- 
lagenase when they are treated with ILl (14, 23, 28). Natural 
and recombinant ILqs also stimulate hyaluronic acid produc- 
tion by fibroblasts  (AEP; submitted for publication). Prepa- 
rations of natural IL-1 have also been shown to stimulate 
prostaglandin E2  (PGE2) production by synoviocytes and 
￿9  The Rockefeller University Press, 0021-9525/88/02/311/8 $2.00 
The Journal of Cell Biology, Volume 106, February  1988 311-318  311 chondrocytes  (15, 23,  39).  Natural  IL-1  has also been re- 
ported to stimulate production of tissue inhibitor of metal- 
loproteinase (TIMP) by fibroblasts (24). 
Although many of these studies attributing various biolog- 
ical activities to IL-1  were performed with highly purified 
preparations,  there is the possibility that a  given biologic 
effect noted with such IL-1  preparations  could be due to a 
potent copurified contaminant.  Because IL-1 has been pro- 
duced through recombinant DNA techniques, it is now pos- 
sible to clearly define its biologic properties. Two human IL- 
l (r  and 13)-specific cDNAs have been cloned and expressed 
in Escherichia coli (1, 21). The human IL-113 gene, when ex- 
pressed in E. coli, yields a protein that has 26 % homology 
with IL-la  (21). 
Studies in experimental models of tissue regeneration have 
established that macrophages are essential for normal repair 
of the matrix that comprises scar tissue. Human monocytes 
when  stimulated  by lipopolysaccharide  produce  10 times 
more IL-113 mRNA than IL-lct mRNA. Therefore, IL-11~ ap- 
pears to be the predominant species produced in these cells 
(21). It is also known that the healing phase of wounding is 
characterized by an increase in fibroblast mitogenic activity 
and synthesis of hyaluronic acid, collagen, and collagenase 
as the fibroblasts attempt to repair and remodel the extracel- 
lular matrix they synthesize. 
In the present study, we present data that show fibroblast 
synthesis of procollagen  type I,  and  steady-state levels of 
its  cognate  mRNAs are  also  increased by human  recom- 
binant (hr) IL-la and IL We have also compared the effects 
of hrlL-1Q  and  13 on other fibroblast functions,  including 
production of coUagenase, TIME and PGE2, and prolifera- 
tion and chemotaxis. We have observed that both IL-ls stimu- 
late all of these fibroblast functions except chemotaxis. We 
found some differences in the potency of hrlL-lct and 13 with 
regards  to production  of PGE2.  Implications  of these ob- 
servations in relation to postinflammatory regeneration are 
discussed. 
Materials and Methods 
Materials 
Homogeneously pure hrlL-I a  and 13 prepared from E. coli were obtained 
from Genzyme Corp., Boston, MA. These IL-la and 13 preparations cor- 
respond to the pl 5 and pI 7 forms of IL-I, respectively, and have been previ- 
ously  described by  March et al.  (21).  These preparations were equally 
potent in stimulating murine thymocyte proliferation in the presence of sub- 
mitogenic doses of pbytohemagglutinin. Maintenance medium used in all 
cultures was MEM supplemented with nonessential amino acids, ascorbic 
acid (50 txg/ml), amphoteracin B  (1  gg/ml), penicillin (100 U/ml), strep- 
tomycin (100 ltg/ml), and 9% heat-inactivated FCS. These were purchased 
from GIBCO, Grand Island, NY.  Radiochemicals [2,3- 3H]proline (115 and 
20 Ci/mmol),  [3H]TdR  (sp act,  1.9 Ci/mmol),  [~4C]acetic  anhydride (sp 
act,  8.9  mCi/mmol),  [35S]methionine (sp act,  >1,200  Ci/mmol),  [32P]d 
CTP (sp act, 3,000 Ci/mmol), Enhance, and Aquasol were purchased from 
New England Nuclear, Boston, MA. Trypsin (TRPTPCK) was purchased 
from Worthington Biochemical Corp., Freehold, NJ. Soybean trypsin inhib- 
itor was purchased from Sigma Chemical Co.,  St. Louis, MO. 
Fibroblast Cultures 
Fibroblast monolayers were cultured in 100-mm patri dishes from explants 
of infant foreskins by standard techniques. Fibroblasts in the 4-12 passage 
were harvested from stock cultures by trypsinization and used in assays to 
measure various fibroblast functions. 
Quantitation of  CoUagenous and Nopxollagenous 
Protein Synthesis 
Fibroblasts were seeded in wells of Falcon 3008 multiweil plates (5  x  104 
cells/0.5 ml maintenance medium) and grown for 72 h to allow them to reach 
confluency. Because FCS contains a variety of factors that stimulate collagen 
synthesis by  fibroblasts,  all  cultures  in  which  IL-1  effects  on  collagen 
production were measured were performed in serum-free medium as indi- 
cated. Although serum starvation was routinely 72-96 h, we found in pre- 
liminary studies that infant foreskin fibroblasts cultured for up to 96 h do 
not have decreased viability and are morphologically indistinguishable from 
ceils cultured in serum containing medium (data not shown). After fibro- 
blasts reached confluency in serum-containing medium, the medium in each 
well was replaced with 500 ttl serum-free maintenance medium containing 
fresh ascorbic acid (50 ~tglml); 24 h later, medium was replaced with 450 
lxl fresh serum-free medium (minus nonessential amino acids) containing 
ascorbic acid and PBS or different concentrations of hrlL-lct or 13 in PBS 
(50 ~tl volume). 48 h  later,  medium was replaced with fresh sernm-free 
maintenance medium (minus nonessential amino acids) containing 5.0 ~tCi 
[2,3 3H]proline (sp act, 20 Ci/mmol).  Supernatants from each well were 
harvested 24 h later and assayed for levels of collagenase-sensitive protein 
as previously described (30). Standard error of triplicate determinations was 
<15%. Alternatively, confluent fibroblast cultures (100-mm-diameter petri 
dishes) grown for 3 d in maintenance medium containing 9% FCS and then 
for 3  d  more with daily changes of medium to serum-free maintenance 
medium containing fresh ascorbic acid were treated with either hrlL-lct or 
1~ (27.5 pg/ml) for 24 h. Medium was removed from cell monolayers and 
replaced with 2.5 ml of DMEM supplemented with 13 aminopropionitrile 
(50 txg/ml),  fresh ascorbic acid (50 I~g/ml), and either [2,3- 3H]prolina (50 
I~Ci/ml; sp act, 115 Ci/mmol) or [35S]methionine (25 ~tCi/ml). After a 2-4 
h labeling period, the media and cell layers were harvested separately, and 
protease inhibitors were immediately added to the media (final concentra- 
tion, 10 mM N-ethylmaleimide, 20 mM EDTA, and 0.3 mM phenylmethyl- 
sulfonyl fluoride). The proteins were precipitated from the media by adding 
absolute ethanol to a concentration of 33 % (vol/vol) and 20 Ixg of unlabeled 
bovine type I collagen as a carrier protein. After precipitation for 16 h at 
4~  the sample was centrifuged at 10,000 g for 20 rain. The pellet was dis- 
solved in Laemmli buffer with 5 % 2-mercaptoethanol and heated at 100*C 
for 5  min; the polypeptide chains were then separated on a  7.5%  SDS- 
polyacrylamide gel. After electrophoresis of equal aliquots of the labeled 
proteins, the gels were treated with Enhance, dried, and fluorographed. The 
fluorograms were scanned with a LKB laser densitometer coupled with a 
Hewlett-Packard 3390A integrator. As these electrophoretic conditions do 
not separate pro r  and pro r  chains, the values denoted for pro ctl(I) 
represent a combined effect of IL-I on both these polypeptides. The effect 
on total protein synthesis was determined by labeling the ceils with [3SS]me- 
thionine in methionine-free media. Extracellular and cell-associated protein 
synthesis was quantitated by experimental protocols described in detail pre- 
viously (32, 33). An aliquot was precipitated with cold 10% "IV_A, washed 
twice with "IV_A, and incorporated radioactivity was determined in a liquid 
scintillation spectrometer. 
Measurement of  lntraceUular Degradation of  Collagen 
The rate of intracellular degradation of newly synthesized collagen was de- 
ternuned according to the technique described in detail previously (3-33). 
Isolation and Quantitative Analysis of 
Messenger  RNAs 
Total cell RNA was extracted by guanidine thioeyanate solubilization of cells 
and centrifugation of the extract through a cushion of 5.7 M CsCI. An equal 
aliquot (10-20 ~tg) of total RNA was size-fractionated in formaldebyde-l% 
agarose gels, transferred to nitrocellulose sheets, and subjected to Northern 
analysis. The eDNA plasmid probes were nick-translated with [a-32P]dATP 
or [a-32p]dCTP to a specific activity of >5 x  l0  T cpm/l~g of DNA accord- 
ing to published techniques (33,  34).  The nitrocellulose filters were  in- 
cubated in prehybridization buffer for 12-24 h at 42~  The nick-translated 
probes were denatured at 100*C for 10 rain, cooled, and added to hybridiza- 
tion buffer (four parts of prehybridization buffer and one part of 50% 
[wt/vol] dextran sulfate). After hybridization for 18-24 h at 42*C, the RNA 
blots were washed extensively, dried, wrapped in Saran Wrap, and exposed 
to x-ray film at -60"C using Cronex Hi-plus intensifying screen. Radioac- 
tivity in the individual bands was quantitated in a scintillation spectrometer. 
These methods have been described in detail previously (33, 34). 
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ctl[I]) and HF32 (pro-ct2[I]), recombinant clones containing 1.8 and 2.2 kb 
of DNA complementary to human pro-oil(I) and pro-a2(I) mRNAs, respec- 
tively (5, 25).  These clones were a  kind gift of Dr.  E  Ramirez,  Rutgers 
University  Medical  School,  Piscataway,  NJ.  Dr.  Richard  Hynes,  Mas- 
sachusetts Institute of Technology, Cambridge,  MA, generously provided 
a eDNA clone of rat fibronectin (35) for analysis of fibronectin mRNAs. 
A full-length eDNA clone of chicken cytoplasmic 13-actin (8) was obtained 
from Dr. D. W. Cleveland, Johns Hopkins University School of Medicine, 
Baltimore,  MD. 
lqbroblast CoUagenase and TIMP Production 
Fibroblasts were seeded in wells of Falcon 3008 multiwell plates (5  x  104 
cells/500  gl maintenance medium).  After 72  h  culture,  medium  was re- 
moved from each well and replaced with maintenance medium (450 gl) con- 
taining 5% FCS and 50 gl of sample being tested. Plates were incubated for 
24 or 48 h, at which time medium was collected from each well. Culture 
supernatants were preincubated with trypsin to activate latent collagenase 
as previously described (28). Collagenolytic activity against type I collagen 
in fibroblast culture supernatants was measured by using a modification (28) 
of a microassay previously described by Johnson-Wint (17).  Alternatively, 
levels of TIMP and collagenase produced by fibroblasts during culture were 
measured by specific ELISA techniques as previously described (7). 
Immunoprecipitation of  CoUagenase and TIMP 
Cell monolayers were exposed to hrIL-lct and [3 for 24 h and were then la- 
beled  with  [35S]methionine (25  IXCi/mi)  for 2  h.  Collagenase  or  TIMP 
polypeptides were immunoprecipitated using monospecific rabbit anti-hu- 
man antibodies against skin collagenase or TIMP as described extensively 
in our previous publications (7, 36). Immunoprecipitated radiolabeled poly- 
peptides were solubilized by boiling for 3 rain in Laemmli sample buffer, 
subjected to gel  electrophoresis,  fluorographed,  and quantitated by laser 
densitometry (7). 
Fibroblast Proliferation 
Harvested flbroblasts were suspended in maintenance medium at a density 
of 1.5  x  104 cells/nil and dispensed (200  I.tl/well)  into microtiter plates. 
After 6  h  incubation to allow cells to attach to the bottom of each well, 
medium  was  replaced  with  200  gl  serum-free  maintenance medium  to 
which BSA (0.5%)  was added and cultured  for 48 h.  Medium  was then 
replaced  with  150  gl  fresh  serum-free  maintenance medium  containing 
0.5% BSA. IL-1 ct, IL-11~, or PBS (50 I.tl) were added to triplicate wells, and 
24 h later each well was pulsed for 16 h with 20 I.tl (1 gCi) of [3H]TdR.  Fi- 
broblasts were rinsed twice, trypsinized (200 gl, 0.25%; 37~  for 1 h), and 
then harvested onto paper filters with a  multiple sample harvester. After 
drying overnight, filters were counted in a scintillation spectrometer. Final 
proliferative activity was expressed as the mean counts per minute of the 
replicates;  standard error of the replicates was <20%  of the mean. 
Prostaglandin E2 Measurements 
In experiments comparing the effects of different doses of hrIL-lct and 13 on 
PGE2 production, fibroblasts at confluent density after 3 d  in maintenance 
medium (9%  FCS)  in multiwell plates were then put in 2.5%  FCS (450 
gl/well) and 50 Ixl of PBS or hrlL-lct and 1~ were added to each well for 
24 h  additional incubation.  PGE2 was then measured in these culture su- 
pernatants.  PGE2  was  extracted from fibroblast culture supernatants and 
measured by a previously described radioimmunoassay technique (12). 
Fibroblast Chemotaxis 
Chemotaxis  was  performed  using  fibroblasts  in serum-free  maintenance 
medium as indicator cells as previously described using modified blind well 
Boyden chemotaxis chambers equipped with gelatin-coated polycarbonate 
filters having eight micron pores (31). 
Results 
Effect of  lL-I on Collagen and Noncollagen 
Protein Synthesis 
We tested the effect of IL-1 on synthesis of type I collagen 
by two alternative  ways.  First, the incorporation of [3H]pro- 
line into total collagenase-sensitive peptides was assessed in 
the presence and absence of hrILq ct and 13. Both IL-ls stimu- 
lated production of collagen in a dose-dependent manner; the 
dose-response  curves  were  bell-shaped  with maximal  re- 
sponse to hrIL-la (165 % stimulation) and 13 (250%  stimula- 
tion) occurring at concentrations of 27.5  and 55 pg/ml,  re- 
spectively (data not shown). Six randomly selected fibroblast 
lines were examined for the effect of IL-ls on collagen pro- 
duction.  Four of the six lines produced significantly  more 
collagen (2.1-2.8-fold)  when exposed to either hrIL-lct  or 13 
(P < 0.001 by Student's two sample t test). Two of the six lines 
did  not  respond  to  hrIL-lct.  One  of these  lines  (HR24B) 
responded  strongly  to  hrIL-113 (6.2-fold  stimulation,  P  < 
0.001),  whereas the other (HF62P) had only a modest (1.2- 
fold stimulation;  P <  0.005) response to hrIL-113. Although 
the response is variable amongst different cell lines,  these 
data suggest that most human foreskin fibroblast  lines will 
increase their production of collagen when exposed to IL-1 ct 
or  13. 
IL-1 stimulation of collagen production by conflent fibro- 
blasts was not associated with significant increases in fibro- 
blast growth (data not shown). 
The results obtained by the coUagenase-sensitive protein 
assay  were further corroborated by electrophoretic analysis 
of [3H]proline-labeled polypeptides released into the extra- 
cellular medium, which showed that the synthesis of type I 
collagen in hrIL-lct- and 13-treated cells was stimulated (Fig. 
1); the densitometric quantitation of the fluorograph  revealed 
Figure 1.  Fluorograph of NaDOdSo4/7.5 %  PAGE analysis of cellu- 
lar  and  extracellular  proteins  synthesized  in  PBS-,  hrlL-la-  or 
13-treated (27.5  pg/ml each) human fibroblasts.  Cells  were  labeled 
with [35S]methionine (A) or [3H]proline (B) and total cellular (first 
three  lanes from left in A) and extracellular  (last three lanes  in A 
and all three lanes in B) proteins were analyzed according to proce- 
dures  outlined  in Materials  and  Methods.  The  extracellularly  re- 
leased polypeptides were precipitated in 30 %  (vol/vol) ethanol and 
processed  for electrophoretic  analysis. 
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lagen chains in the hrlL-1 ~t- and 13-treated cells (data omit- 
ted). Two other smaller polypeptide species marked x and 
y (Fig. 1) are collagenase-sensitive and are probable break- 
down products of  coUagens (Raghow, R., unpublished obser- 
vation). 
We evaluated the specificity of the effect of IL-1 treatment 
on cellular protein synthesis by analyzing [35S]-radiolabeled 
cell-associated and extracellularly-released polypeptides by 
SDS-PAGE  and fluorography. Treatment of human fibro- 
blasts with hrlL-la or 13 had a minor stimulatory effect on 
total cell-associated proteins (Fig. 1). The results from den- 
sitometric quantitation and determination of total TCA-pre- 
cipitable  incorporation  of [35S]methionine  or  [3H]proline 
into cellular and extracellular proteins confirmed the visual 
impression of  the results illustrated in the fluorograph. There 
was a  <20%  increase in cell-associated and extracellular 
proteins  in cultures  treated with hrlL-10t  or  13  (data  not 
shown). The electrophoretic pattern of [35S]methionine-la- 
beled polypeptides synthesized and released into the extra- 
cellular medium, however, showed three polypeptides whose 
synthesis was significantly altered in IL-l-treated cells (Fig. 
1). The largest of  these polypeptides a 59/52-kD doublet was 
identified as fibroblast collagenase by immunoprecipitation 
(see  following).  Because methionine is  extremely under- 
represented  in  collagens  compared  with  noncollagenous 
polypeptides, the modulatory effect of II-ltx and 13 on pro 
~tl(I) and pro tz2(I) cannot be accurately determined using 
[3SS]methionine-labeled samples (37, 38). However, the stim- 
ulatory effect of IL-1 on pro la(I) and pro ~t2(I) chains is 
clearly evident in [3H]proline-labeled  extracellular samples 
(Fig.  1). 
We determined whether the increased collagen synthesis 
in hrIL-1 a- and 13-treated cells (same cell line used in experi- 
ments in Fig. 1) was reflected in the steady-state accumula- 
tion of their cognate mRNAs. Total RNA, the EtBr staining 
pattern of which is shown in Fig. 2, was transferred to nitro- 
cellulose filters and probed with nick-translated cDNA plas- 
mids  specific  for pro  a(I),  fibronectin,  and  cytoplasmic 
13-actin. There were no significant differences in the steady- 
state levels of fibronectin and 13-actin mRNAs between con- 
trol and IL-l-treated cells based on three separate determina- 
tions. However,  the relative steady-state levels  of pro ~tl(I) 
mRNAs  (Fig.  2)  were  approximately  1.5-2-fold  in  IL-1- 
treated cells. The steady-state levels of pro tz2(I) mRNAs 
were similarly stimulated by IL-1 treatment (data not shown). 
It appears, therefore, that hrlL-l~t and 13 preferentially in- 
creased the transcription and/or stability of type I procolla- 
gen mRNAs. 
Effect on hrlL-1 a on lntraceUular  Degradation 
of Collagen 
The relative rates of intracellular collagen degradation were 
found to remain unaltered in hrIL-l-treated fibroblasts.  Fi- 
broblasts cultured with PBS as a control degraded 40 +  4 % 
and with hrlL-lct (27.5 pg/ml) degraded 44  +  5% of newly 
synthesized collagen. 
Synthesis of  CoUagenase and TIMP by 
IL-l-treated Cells 
When the same fibroblast line was cultured separately with 
different doses of hrIL-Iet and 13, we found each stimulated 
Figure 2. Blot hybridization of mRNAs from IL-l-treated cultured 
human fibroblasts. Cellular RNA (15 gg/lane) from untreated (con- 
trol), IL-lct- or I]-treated (27.5 pg/ml; 24 h) were size-fractionated 
in formaldehyde-agarose  gels, transferred to nitrocellulose, and hy- 
bridized to nick-translated cDNA plasmids. EtBr-stained gel (A) 
and fluorographs representing Northern analyses of fibronectin 
(B), pro ctl(I), and I$-actin (D) mRNAs are shown. 
collagenase production (as assessed by lysis of ~4C-labeled 
type I collagen gels) at similar concentrations in a dose-de- 
pendent manner (data not shown). 
A partially purified preparation of IL-113 has been shown 
to stimulate TIMP production by fibroblasts (24). We inves- 
tigated the effect of hrlL-lct and 13 on the biosynthesis of 
TIMP in four randomly selected human dermal fibroblast 
cell lines and also measured collagenase levels in the same 
supernatants from these four cell lines to determine whether 
TIMP and collagenase biosynthesis were coordinately regu- 
lated. All four lines produced more TIMP and collagenase 
when cultured with hrlL-la and I]; generally the stimulation 
of  collagenase by IL-ls was much greater (three- to eightfold) 
compared with that of TIMP (1.5-2-fold). 
Because the ELISA protocol for coUagenase  and TIMP 
measurement could not distinguish between the synthesis 
and accumulation of these proteins, we directly determined 
the effect of IL-l-treatment on the synthesis of coUagenase 
and TIMP by immunoprecipitation of [35S]methionine  la- 
beled proteins.  Our results show that both hrIL-la and 13 
stimulate the rate of biosynthesis of collagenase equally well 
(Figs.  1 and 3); both IL-lct and 13 increased the rate of col- 
lagenase synthesis eight- to ninefold (Table I). Interestingly, 
the effect of hrIL-1Q and 13 (each at a concentration of 27.5 
pg/ml) on the synthesis of immunoprecipitable TIMP was 
quite different from their effect on collagenase synthesis. 
Whereas hrIL-l~t caused a sevenfold increase in TIMP syn- 
thesis at this concentration, hrIL-113 had no measurable effect 
(Table I). However, when these same fibroblasts were stimu- 
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phoretic analysis of biosyntheti- 
cally labeled collagenase  polypep- 
tides from control or IL-1  a-treated 
(27.5  pg/ml)  cells.  Fibroblasts 
were  labeled  with  [35S]methio- 
nine and polypeptides released in 
the media were immunoprecipi- 
tated using anticollagenase anti- 
bodies.  Synthesis of collagenase 
was stimulated to a similar degree 
by hrlL-la and  13; results from 
the former are shown. 
lated with a higher dose (1.1 ng/ml) of hrlL-lct and 13, mean 
TIMP levels in the culture medium by the ELISA technique 
were 260 +  13 (P <  0.001) and 210 +  32 ng/ml (P <  0.05), 
respectively (mean TIMP level in unstimulated cultures was 
164  4-  8 ng/ml). These data suggest that at low concentra- 
tions, IL-113 can stimulate biosynthesis of collagenase while 
not affecting the biosynthesis of TIME 
Fibroblast Proliferation 
hrIL-lct has been shown to stimulate human dermal fibro- 
blasts at subconfluent density to proliferate (18). We assessed 
and  compared the effects of hrIL-Ict and  13 on fibroblast 
proliferation. Both IL-ls stimulated  (up to three- to four- 
fold) proliferation of  subconfluent fibroblasts as measured by 
[3H]thymidine uptake in a dose-dependent manner and were 
of equal potency at the concentrations tested (0.2-100 pg/ml) 
(data not shown). Because this assay does not discriminate 
between uptake of thymidine and its incorporation into DNA, 
we assessed the proliferative  effects of  the IL-ls on fibroblasts 
directly. The mean number of cells  (￿  10  -3)  per well  + 
SEM after 4 d culture with PBS or the IL-ls was as follows: 
0.9% NaCI,  13.2 +  0.7; hrIL-lct, 26.6 +  1.5; and hrIL-113, 
24.6 4- 3.8. Statistical analysis by Student's t test showed that 
the values for hrIL-l~t and 13 were significantly greater than 
control (P <  0.0025 and P  <  0.025,  respectively). 
Prostaglandin Ez Metabolism in IL-treated Cells 
Other investigators have demonstrated that the metabolism of 
PGE2 is intimately related to fibroblast growth and the bio- 
synthesis and degradation of collagen (6). Although dermal 
fibroblasts have been shown to produce PGE2 in response to 
hrIL-ltx and 13, no study to date has compared the response 
of the same target cell line to the recombinant IL-ls (11). We 
observed that hrIL-lct and 13 are able to stimulate fibroblast 
PGE2  production,  however,  hrIL-l~t  is  more  potent  than 
hrlL-113 (data not shown). At a dose of  20 pg/ml, hrIL-1  ct and 
13  stimulated  production of PGE2 to  levels of 54  and  17 
ng/ml, respectively. We have tested several different lots of 
hrlLdct and 13 and have found a  similar disparity in their 
potency with regard to stimulation of fibroblast PGFa pro- 
duction (data not shown), hrIL-1  ct was always  more potent 
Table L Effect ofhrlL-la and [3 on the Synthesis of 
Collagenase and TIMP 
Treatment 
Polypeptide  Control  hrIL-  1  ~t  hrlL-  113 
Collagenase* 
TIMP* 
arbitrary  arbitrary  arbitrary 
absorbance  absorbance  absorbance 
units  units  units 
1.02  8.28  9.31 
(100)  (811.7)  (912.7) 
0.85  6.09  0.83 
(100)  (716.4)  (97.6) 
* Fibroblast monolayers  were  treated with PBS (control),  hrlLct, or 13 (27.5 
pg/ml) for 24 h and labeled  with [~S]methionine  as described  in the Methods 
section. Aliquots of pulse-labeled extracts were electrophoresed  after im- 
munoprecipitation  with  antiserum  against eollagenase  and TIMP. Arbitrary  ab- 
sorbance units derived from autoradiogram represented polypeptide  bands 
immunoprecipitated  by antisera for collagenase  or TIMP  are given. The num- 
bers in parentheses  represent  values compared  with control  which is given  a 
value of 100. 
than hrlL-113, and the maximal levels of PGE2 produced in 
response to hrlL-la were always  higher than that seen in 
hrlL-l~treated cells. Others have demonstrated that PGE2 
can suppress fibroblast collagen production and proliferation 
(6); Dayer et at. also observed that inhibition of PGE2 syn- 
thesis by indomethacin often reduced coUagenase production 
by mononuclear cell  factor (MCF,  IL-1)-treated adherent 
rheumatoid synovial cells, but stimulated collagen produc- 
tion (9). In view of these findings, we assessed the effect of 
indomethacin-mediated  inhibition  of  PGE2  synthesis  on 
other fibroblast functions modulated by IL-1.  Inhibition of 
PGE2 synthesis by pretreating fibroblasts with indometha- 
cin had a global effect by increasing [3H]thymidine uptake 
and incorporation by subconfluent fibroblasts (Table II). In 
contrast to previous observations with adherent rheumatoid 
synovial cells  (9),  inhibition of PGE2  synthesis  by fibro- 
blasts treated with indomethacin had no significant effect on 
the ability of hrlL-1 r  and 13 to stimulate fibroblast prolifera- 
tion or production of collagen and collagenase (Table II), 
suggesting that IL-1 modulates these fibroblast functions via 
PGE2-independent pathways.  We have repeated these studies 
on three different cell lines and have obtained similar results 
(data not shown). 
Fibroblast Chemotaxis 
Because natural IL-1 has been reported to induce chemotaxis 
of lymphocytes, neutrophils, and monocytes (1,  18, 20, 22), 
we quantitated the degree of migration of fibroblasts in the 
presence of  hrlL-ltt and IL Serial dilutions of the IL-ls rang- 
ing from 1.7 to  110 pg/ml were tested. Neither preparation 
was capable of inducing fibroblast chemotaxis. The number 
of fibroblasts migrating in the presence of various concentra- 
tions of IL-1  ~t and I~ tested were not significantly different 
from the PBS control (5 +  1 fibroblasts per 20 oil immersion 
felds). In the same assay,  fibroblasts migration to a known 
chemoattractant (denatured type I bovine collagen) was 63 
+8. 
Discussion 
The present study was undertaken to investigate several im- 
portant parameters of fibroblast biology and the ability of 
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hrIL-la, pretreatment  hrlL-113, pretreatment  PBS, pretreatment 
Condition*  Indomethacin  Buffer  Indomethacin  Buffer  Indomethacin  Buffer 
Experiment 1 
Proliferation (mean CPM J: SEAl) 
PGE2 production (mean pg/well :~ SEM) 
Experiment 2 
Collagen production (mean CPM :t: SEM) 
PGE2 production (mean pg/welt J: SEM) 
Experiment 3 
Collagenase activity (mean  ~g gel lysis j: SEM) 
PGEz production (mean pg/well 5: SEM) 
7594  •  1150  4584  •  7098  •  5312  •  1946+417  1149  • 
22  +  4.5  130  •  35  13  •  1.1  120  •  32  13  •  0.2  14  •  0.4 
2865  •  265  2860  •  240  2971  •  78  2884  •  230  1948  •  230  1869  •  70 
30  •  5  5537  •  14t9  26  •  3  193  •  21  28  •  4  34  •  1 
47  +  7  35  +  2  42  •  2  48  •  3  14  •  16•  1 
19  •  1.1  1837  •  394  29  •  2.4  2134  •  212  24  +  1.5  27  •  0.5 
* Fibroblast proliferation and production of PGE2, collagen, and collagenase were each quantitated in different fibroblast lines as described in Materials and 
Methods in the presence and absence  of hrIL-i a and hrIL-113 (i.e., for proliferation, 72 h in serum-free maintenance  medium containing 0.5 % B  SA; for collagen 
production, 48 h in serum-free maintenance  medium without nonessential  amino acids; for collagenase, 24 h in maintenance  medium containing 5% FCS), with 
and without  the addition  of indomethacin.  The concentrations  of  hrlL-1  a and I~ in experiments 1,2, and 3 were 110, 13.8, and 55 pg/ml, respectively.  Indomethacin 
(1 rag, Sigma Chemical Co.) was solubilized in DMSO (0.1 ml with 100 mM NaHCO3). The control consisted of DMSO and 100 mM NaHCO3. All further 
dilutions of indomethacin  were made in PBS. Fibroblasts were preincubated  with indomethacin  (1 pg/ml) or control for 6 h at 37~  PBS, hrIL-la, or hrIL-113 
were added to the culture without further changes of medium. PGE2 levels represent that accumulated during the final 24 h of culture in each experiment. 
hrlL-1 a and 13 to modulate them. Our results confrm and ex- 
tend  observations  of several  other  studies.  We  show that 
hrlL-1 a  and 13 stimulate the synthesis of type I procollagens 
as well as their cognate mRNAs, suggesting that a pretransla- 
tional mechanism is involved in this effect. The recombinant 
ILls exhibited similar potency in stimulating fibroblast col- 
lagen production. IL-1 did not stimulate noncollagenous pro- 
tein synthesis by >20%, and the steady-state levels of fibro- 
nectin  and  13-actin mRNAs  did  not  change  after  IL-1 
treatment  of fibroblasts.  The  intracellular  degradation  of 
newly synthesized collagen was also not altered by the ILls, 
and the effect of IL-ls on collagen synthesis appears to be 
mediated  by  a  PGE2-independent  pathway(s).  To  our 
knowledge, this is the first conclusive evidence that IL-1 a or 
13 can stimulate synthesis of type I collagen by dermal fibro- 
blasts.  Earlier  studies by Amento et al.  and Krane et al. 
demonstrated that conditioned media from cultures of adher- 
ent human  peripheral  blood mononuclear  leukocytes were 
capable of stimulating adherent rheumatoid synovial fibro- 
blastlike  cells to  synthesize  collagen  (2,  19).  This  condi- 
tioned medium did contain mononuclear cell factor (IL-1), 
but it is possible that it contained other factors such as trans- 
forming growth factor 13 and T cell-derived lymphokine that 
are both capable of stimulating fibroblasts to synthesize col- 
lagen (30,  34). In addition,  the adherent cells that are ob- 
tained from synovial tissue of patients with rheumatoid ar- 
thritis are a heterogeneous population of cells composed of 
fibroblast- and macrophagelike  cells that are morphologi- 
cally and  metabolically  very different  from dermal  fibro- 
blasts (16). Data obtained from studies employing such syno- 
vial cells may not be relevant to dermal fibroblasts because 
they may also be influenced by cell-ceU interactions between 
the macrophage- and fibroblastlike cells. 
Fibroblast collagenase and TIMP synthesis, proliferation 
and  PGE2 production  were stimulated  by hrlL-la  and  13. 
Whereas both IL-ls were of similar potency in stimulating 
proliferation,  collagenase,  and TIMP production,  hrlL-la 
was more potent than hrlL-113 in stimulating fibroblasts to 
synthesize PGE2. Our data confirm and extend the observa- 
tions published by others which suggest that IL-1 modulates 
these fibroblast functions (2, 10, 14, 19, 23, 24, 34). We have 
recently observed that natural human IL-113 and hrlL-la and 
13 stimulate fibroblasts to synthesize increased amounts of 
hyaluronic  acid but not other glycosaminoglycans (Postle- 
thwaite, A.  E.,  submitted for publication). 
Although PGE2 is able to suppress fibroblast growth and 
collagen production,  blocking the synthesis of PGE2 with 
indomethacin was found to have no effect on the degree to 
which hrlL-l~t or 13 stimulated cell proliferation or collagen 
production. Collagenase synthesis by fibroblasts treated with 
hrIL-la  and 13 was not altered by indomethacin  treatment. 
Furthermore, we have shown that inhibiting PGE2 synthesis 
also does not alter the ability of hrlL-la and 13 to stimulate 
hyaluronic acid synthesis by fibroblasts (Postlethwaite,  A. E., 
submitted for publication).  These results suggest that these 
IL-1  effects on fibroblasts are mediated via PGF_a-indepen- 
dent pathways. Previous studies with partially purified IL-1- 
treated  synovial cells have shown that  stimulation  of col- 
lagenase production by IL-1 was reduced in the presence of 
indomethacin (9). Furthermore,  stimulation of adherent sy- 
novial cell proliferation and collagen production by mono- 
nuclear  leukocyte culture supernatants  containing  IL-1  has 
been observed only in the presence of indomethacin  (19). 
The fact that both species of human IL-ls stimulate many 
fibroblast functions is of considerable interest when one tries 
to relate the structure of each molecular species to its biologi- 
cal functions.  IL-lct and 13 have only 27%  amino acid se- 
quence homology (21).  Our observations clearly point to- 
wards the existence of common functional domains  in the 
homologous portions of the two IL-1 species. Whether the 
common functional domains correlate with structurally ho- 
mologous regions in these molecules is yet to be resolved. 
Human fibroblast lines maintained in vitro have high levels 
of receptors for native human IL-113 (13). IL-1 tt and 13 appear 
to bind  to the  same high-affinity  receptors  on fibroblasts 
(4). For the LBRM 33/5, an ILd-dependent mouse thymoma 
cell line which binds ,x,500 IL-1 molecules per cell at satura- 
tion, IL-la  seems to compete equally well with IL-113 for 
binding (14). 
We have demonstrated  in this study that both the major 
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blast  functions;  these  include  stimulation  of  growth  and 
prostaglandin production as well as elevated rates of synthe- 
sis of collagen and/or release of collagenase. The IL-ls were 
also able to stimulate fibroblast synthesis of TIME  which 
likely plays a key role in modulating collagenase activity. IL- 
let  and 13 also  stimulate  fibroblast synthesis  of hyaluronic 
acid, which facilitates cell migration (Postlethwaite,  A.  E., 
submitted for publication).  Although IL-l~t  and 13 are not 
chemotactic for fibroblasts, they could be indirectly respon- 
sible for stimulating fibroblast migration to the repair site by 
virtue of their ability to stimulate collagen and collagenase 
synthesis. Type I collagen and collagen peptides are chemo- 
tactic for fibroblasts (29).  Therefore,  we suggest that IL-1 ct 
and 13 may play a critical role in the repair response that fol- 
lows tissue injury by a variety of immune and nonimmune 
mechanisms. Because a number of different stimuli can trig- 
ger release of IL-1 from macrophages including lipopolysac- 
charide, immune complexes, phagocytosis, and lymphokines 
(1,  14),  IL-1  would be  expected  to be  present  in  the  vast 
majority of inflammatory reactions. The precise outcome of 
the  regenerative  process  would be highly  dependent  on a 
complex array of interactive pathways that generate IL-1 and 
other modulators of fibroblast chemotaxis, growth, and ma- 
trix component synthesis and degradation. 
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